See more : Claranova SE (0N6K.L) Income Statement Analysis – Financial Results
Complete financial analysis of PT Indo Acidatama Tbk (SRSN.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Indo Acidatama Tbk, a leading company in the Chemicals industry within the Basic Materials sector.
- OncoSec Medical Incorporated (ONCSQ) Income Statement Analysis – Financial Results
- Ricoh Company, Ltd. (RICO.L) Income Statement Analysis – Financial Results
- GEO JS Tech Group Corp. (GJST) Income Statement Analysis – Financial Results
- Avant Brands Inc. (AVNT.TO) Income Statement Analysis – Financial Results
- Azkoyen, S.A. (AZK.MC) Income Statement Analysis – Financial Results
PT Indo Acidatama Tbk (SRSN.JK)
About PT Indo Acidatama Tbk
PT Indo Acidatama Tbk produces and sells basic and agro chemicals primarily in Indonesia. The company offers ethanol, acetic acid, and ethyl acetate products; and organic plus bio fertilizers under the POMI, RANDEX, ALFINASE, and BEKA names. It also exports its products. The company was formerly known as PT Sarasa Nugraha Tbk and changed its name to PT Indo Acidatama Tbk in May 2006. PT Indo Acidatama Tbk was founded in 1982 and is based in West Jakarta, Indonesia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,026.71B | 977.71B | 907.83B | 891.00B | 684.46B | 600.99B | 521.48B | 500.54B | 531.57B | 472.83B | 392.32B | 384.15B | 387.35B | 342.87B | 352.54B | 313.92B |
| Cost of Revenue | 793.36B | 792.04B | 740.04B | 699.83B | 511.52B | 458.09B | 407.41B | 410.84B | 417.47B | 376.49B | 306.04B | 302.81B | 299.75B | 275.04B | 262.91B | 200.64B |
| Gross Profit | 233.35B | 185.66B | 167.79B | 191.17B | 172.94B | 142.90B | 114.07B | 89.70B | 114.11B | 96.35B | 86.28B | 81.34B | 87.61B | 67.83B | 89.63B | 113.28B |
| Gross Profit Ratio | 22.73% | 18.99% | 18.48% | 21.46% | 25.27% | 23.78% | 21.87% | 17.92% | 21.47% | 20.38% | 21.99% | 21.17% | 22.62% | 19.78% | 25.42% | 36.09% |
| Research & Development | 568.88M | 680.85M | 1.01B | 1.64B | 1.89B | 1.78B | 1.82B | 1.63B | 1.10B | 2.32B | 1.17B | 1.86B | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | -4.92B | 9.51B | 8.76B | 9.91B | 9.21B | 8.30B | 8.00B | 7.75B | 10.06B | 9.33B | 8.48B | 7.73B | 34.43B | 29.61B | 29.07B | 32.02B |
| Selling & Marketing | 149.65B | 85.55B | 62.00B | 54.97B | 44.80B | 28.32B | 23.55B | 20.94B | 33.14B | 12.77B | 10.05B | 10.80B | 13.78B | 14.85B | 16.28B | 12.29B |
| SG&A | 144.83B | 95.05B | 70.76B | 64.88B | 54.01B | 36.62B | 31.55B | 28.68B | 43.20B | 22.10B | 18.52B | 18.53B | 48.20B | 44.45B | 45.35B | 44.30B |
| Other Expenses | 0.00 | 40.74B | 38.54B | 45.33B | 46.26B | 762.91M | 242.81M | 1.10B | -335.88M | -533.66M | 676.18M | 237.18M | -558.10M | -191.75M | -2.71B | -3.79B |
| Operating Expenses | 145.30B | 136.47B | 110.32B | 111.84B | 102.16B | 82.61B | 73.66B | 67.68B | 80.15B | 58.78B | 51.49B | 51.94B | 47.65B | 45.30B | 47.99B | 48.16B |
| Cost & Expenses | 938.44B | 928.52B | 850.36B | 811.68B | 613.68B | 540.70B | 481.07B | 478.52B | 497.62B | 435.27B | 357.53B | 354.75B | 347.39B | 320.34B | 310.90B | 248.79B |
| Interest Income | 6.95M | 9.08M | 10.64M | 17.92M | 531.67M | 11.71M | 13.48M | 43.40M | 161.76M | 128.88M | 53.60M | 74.67M | 67.96M | 133.50M | 481.11M | 283.22M |
| Interest Expense | 13.47B | 13.70B | 24.27B | 20.82B | 13.71B | 14.07B | 22.38B | 18.24B | 14.81B | 9.97B | 7.27B | 5.49B | 4.22B | 7.91B | 13.57B | 10.14B |
| Depreciation & Amortization | 16.81B | 15.35B | 14.91B | 15.64B | 13.75B | 11.83B | 11.80B | 10.40B | 1.49B | 1.38B | 1.29B | 1.12B | 85.72M | 849.91M | 2.64B | 3.85B |
| EBITDA | 104.86B | 73.48B | 71.44B | 97.48B | 85.27B | 76.75B | 52.81B | 28.84B | 44.04B | 50.72B | 50.32B | 32.92B | 48.26B | 33.13B | 63.11B | 58.30B |
| EBITDA Ratio | 10.21% | 6.29% | 6.95% | 9.57% | 10.73% | 11.17% | 8.10% | 4.33% | 7.68% | 8.62% | 10.30% | 8.16% | 10.49% | 7.63% | 14.05% | 18.57% |
| Operating Income | 88.26B | 58.13B | 56.53B | 81.84B | 70.74B | 64.92B | 41.35B | 19.93B | 35.52B | 39.83B | 39.94B | 31.25B | 39.96B | 22.53B | 41.64B | 65.13B |
| Operating Income Ratio | 8.60% | 5.95% | 6.23% | 9.19% | 10.33% | 10.80% | 7.93% | 3.98% | 6.68% | 8.42% | 10.18% | 8.14% | 10.32% | 6.57% | 11.81% | 20.75% |
| Total Other Income/Expenses | -13.47B | -13.70B | -24.27B | -20.82B | -13.71B | -14.07B | -22.38B | -18.24B | -14.81B | -9.97B | -7.27B | -5.49B | -4.22B | -8.16B | -5.13B | -52.56B |
| Income Before Tax | 74.79B | 44.42B | 32.26B | 61.03B | 57.03B | 50.85B | 18.97B | 1.69B | 20.71B | 29.86B | 32.67B | 25.76B | 33.81B | 14.18B | 36.51B | 12.57B |
| Income Before Tax Ratio | 7.28% | 4.54% | 3.55% | 6.85% | 8.33% | 8.46% | 3.64% | 0.34% | 3.90% | 6.31% | 8.33% | 6.71% | 8.73% | 4.14% | 10.36% | 4.00% |
| Income Tax Expense | 16.77B | 10.78B | 5.71B | 16.88B | 14.20B | 12.11B | 1.27B | -9.37B | 5.21B | 15.40B | 16.67B | 8.80B | 9.82B | 4.35B | 11.13B | 5.77B |
| Net Income | 58.02B | 33.64B | 26.54B | 44.15B | 42.83B | 38.74B | 17.70B | 11.06B | 15.50B | 14.46B | 15.99B | 16.96B | 23.99B | 9.83B | 25.38B | 6.80B |
| Net Income Ratio | 5.65% | 3.44% | 2.92% | 4.96% | 6.26% | 6.45% | 3.39% | 2.21% | 2.92% | 3.06% | 4.08% | 4.41% | 6.19% | 2.87% | 7.20% | 2.17% |
| EPS | 9.64 | 5.59 | 4.41 | 7.33 | 7.11 | 6.43 | 2.94 | 1.84 | 2.58 | 2.43 | 2.66 | 2.82 | 3.98 | 1.63 | 4.22 | 1.13 |
| EPS Diluted | 9.64 | 5.59 | 4.41 | 7.33 | 7.11 | 6.43 | 2.94 | 1.84 | 2.58 | 2.43 | 2.66 | 2.82 | 3.98 | 1.63 | 4.22 | 1.13 |
| Weighted Avg Shares Out | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B |
| Weighted Avg Shares Out (Dil) | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B | 6.02B |
Source: https://incomestatements.info
Category: Stock Reports